EQUITY RESEARCH
NEODECORTECH
RESULTS REVIEW
On Track
Neodecortech delivered strong 9M'22 results, on track to meet its target of matching 2021's exceptional results, despite the challenging macroeconomic environment.
Yesterday, Neodeocortech released its 9M'22 results, which were on track to reach values in line with 2021, a record year for the group.
The 9M performance follows H1's, marked by:
- An increase in selling prices, both for electricity sold on the market by the BEG division and for the other divisions, as a result of costs passed on to customers. BEG benefits in particular from a still very high PUN (average Italian energy price) (average price of €0.472/kWh in Q3'22, 3x higher than in Q3'21 of €0.124/kWh), which helps to compensate for the furniture sector's revenue decline (-6.4% in revenue in Q3'22 vs. Q2'22, source: Istat). As a result, group revenue increased by 20.4% yoy (Q3: +20.5% yoy) to €151m (vs. €125m in 9M'21).
- Margin pressure due to higher raw material costs, which have not yet been fully passed on to customers, leading to a reduction in the EBITDA margin to 10.3% (vs. 11% in 9M'21).
The company's financial structure remains solid and cash generation, as evidenced by a financial leverage still well below 2x and a FCF of €4m (vs. €5m in 9M'21). The latter remains dynamic despite WC consumption amounting to -€11m, mainly due to the advanced purchase of materials to cover cost increases.
Our positive view has been reinforced by:
- 9M results should allow the group to reach FY 2021 revenue, an exceptional year.
- By producing its own energy, the group retains a competitive advantage over those who have to source energy externally at higher prices.
Based on these factors, we are reiterting our estimates (FY 2022 of €185m and EBITDA margin of 9.8%), Buy rating and TP.
Document produced on
4 November 2022 at 1:03am CET
Document published on
4 November 2022 at 8:29am CET
BUY
TP 5.3€
Up/Downside: 84%
Key data
Price (€) | 2.9 |
Industry | Diversified Paper |
Ticker | NDT-IT |
Shares Out (m) | 14.218 |
Market Cap (m €) | 40.8 |
Average trading volumes | 57.248 |
(k shares / day) |
Ownership (%)
Management | 58.6 |
Free float | 41.4 |
EPS (€) | 12/22e | 12/23e | 12/24e |
Estimates | 0.59 | 0.48 | 0.53 |
Change vs previous | 0.00 | 0.00 | 0.00 |
estimates (%) | |||
Performance (%) | 1D | 1M | YTD |
Price Perf | -2.7 | -1.0 | -34.6 |
Rel FTSE Italy | -2.4 | -9.2 | -21.4 |
4.8 | 170 | |||||||||||||||||||||||||
4.6 | 165 | |||||||||||||||||||||||||
4.4 | 160 | |||||||||||||||||||||||||
4.2 | 155 | |||||||||||||||||||||||||
4.0 | 150 | |||||||||||||||||||||||||
3.8 | 145 | |||||||||||||||||||||||||
3.6 | 140 | |||||||||||||||||||||||||
3.4 | 135 | |||||||||||||||||||||||||
3.2 | 130 | |||||||||||||||||||||||||
3.0 | 125 | |||||||||||||||||||||||||
2.8 | 120 | |||||||||||||||||||||||||
2.6 | 115 | |||||||||||||||||||||||||
21 | 21 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | ||||||||||||||
Nov | - | Dec | - | Jan | - | Feb | - | Mar | - | Apr | - | May | - | Jun | - | Jul | - | Jul | - | Aug | - | Sep | - | Oct | - | |
Neodecortech | Rel. to FTSE Italy |
TP ICAP Midcap Estimates | 12/21 | 12/22e | 12/23e | 12/24e | Valuation Ratio | 12/22e | 12/23e | 12/24e | Consensus FactSet - Analysts:3 | 12/22e | 12/23e | 12/24e | ||
Sales (m €) | 176.4 | 184.9 | 191.7 | 197.0 | EV/Sales | 0.4 | 0.3 | 0.3 | Sales | 188.8 | 193.1 | 197.0 | ||
Current Op Inc (m €) | 9.2 | 9.2 | 10.7 | 11.7 | EV/EBITDA | 3.8 | 3.1 | 2.5 | EBIT | 9.0 | 10.1 | 11.7 | ||
Current op. Margin (%) | 5.2 | 5.0 | 5.6 | 5.9 | EV/EBIT | 7.5 | 5.8 | 4.6 | Net income | 9.0 | 6.9 | 7.6 | ||
EPS (€) | 0.49 | 0.59 | 0.48 | 0.53 | PE | 4.8 | 6.0 | 5.4 | ||||||
DPS (€) | 0.14 | 0.19 | 0.16 | 0.19 | ||||||||||
Yield (%) | 4.9 | 6.6 | 5.6 | 6.7 | ||||||||||
FCF (m €) | 8.2 | 0.2 | 9.8 | 11.2 |
Analyst Simone Mieli simone.mieli@tpicap.com 33149241833
Classification: Internal
EQUITY RESEARCH | TP ICAP MIDCAP | 42 rue Washington, 75008 Paris | More on www.midcapp.com
Document downloaded by Simone Mieli (TP ICAP (EUROPE) SA)
Document published on
4 November 2022 at 8:29am CET
FINANCIAL DATA
Income Statement
12/19 | 12/20 | 12/21 | 12/22e | 12/23e | 12/24e |
Sales | 133.0 | 127.8 | 176.4 | 184.9 | 191.7 | 197.0 |
Changes (%) | 1.6 | -3.9 | 38.0 | 4.8 | 3.7 | 2.8 |
Gross profit | 59.7 | 55.3 | 65.1 | 70.9 | 74.2 | 76.5 |
% of Sales | 44.9 | 43.3 | 36.9 | 38.3 | 38.7 | 38.8 |
EBITDA | 15.9 | 14.6 | 18.1 | 18.2 | 20.0 | 21.3 |
% of Sales | 12.0 | 11.4 | 10.3 | 9.8 | 10.4 | 10.8 |
Current operating profit | 7.1 | 5.5 | 9.2 | 9.2 | 10.7 | 11.7 |
% of Sales | 5.4 | 4.3 | 5.2 | 5.0 | 5.6 | 5.9 |
Non-recurring items | -0.1 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
EBIT | 7.1 | 5.5 | 9.2 | 9.2 | 10.7 | 11.7 |
Net financial result | -1.9 | -1.4 | -1.2 | -1.3 | -1.2 | -1.2 |
Income Tax | -1.2 | -0.5 | -1.3 | -3.3 | -2.6 | -2.9 |
Tax rate (%) | 23.9 | 13.0 | 16.6 | 27.9 | 27.9 | 27.9 |
Net profit, group share | 4.0 | 3.5 | 6.7 | 8.4 | 6.8 | 7.6 |
EPS | 0.30 | 0.27 | 0.49 | 0.59 | 0.48 | 0.53 |
Financial Statement | 12/19 | 12/20 | 12/21 | 12/22e | 12/23e | 12/24e |
Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tangible and intangible assets | 81.8 | 79.4 | 80.1 | 80.4 | 80.5 | 80.4 |
Right of Use | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Financial assets | 1.9 | 1.8 | 1.8 | 0.4 | 0.4 | 0.4 |
Working capital | 27.6 | 29.5 | 27.2 | 32.3 | 30.2 | 27.5 |
Other Assets | 2.3 | 2.2 | 2.0 | 2.0 | 2.0 | 2.0 |
Assets | 113.5 | 113.0 | 111.1 | 115.2 | 113.1 | 110.4 |
Shareholders equity group | 61.3 | 61.7 | 70.5 | 76.2 | 80.8 | 85.6 |
Minorities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
LT & ST provisions and others | 0.9 | 1.3 | 1.0 | 1.0 | 1.0 | 1.0 |
Net debt | 40.5 | 39.9 | 29.3 | 27.7 | 21.1 | 13.5 |
Other liabilities | 9.5 | 9.0 | 8.7 | 8.7 | 8.7 | 8.7 |
Liabilities | 113.5 | 113.0 | 111.1 | 115.2 | 113.1 | 110.4 |
Net debt excl. IFRS 16 | 40.5 | 39.9 | 29.3 | 27.7 | 21.1 | 13.5 |
Gearing net | 0.7 | 0.6 | 0.4 | 0.4 | 0.3 | 0.2 |
Leverage | 2.6 | 2.7 | 1.6 | 1.5 | 1.1 | 0.6 |
Cash flow statement | 12/19 | 12/20 | 12/21 | 12/22e | 12/23e | 12/24e |
CF after elimination of net borrowing costs and taxes | 14.0 | 11.9 | 15.8 | 14.6 | 17.1 | 18.1 |
∆WCR | -1.9 | -2.9 | 2.1 | -5.0 | 2.1 | 2.7 |
Operating cash flow | 12.1 | 9.0 | 18.0 | 9.6 | 19.2 | 20.8 |
Net capex | -8.0 | -6.4 | -9.7 | -9.4 | -9.4 | -9.5 |
FCF | 4.1 | 2.6 | 8.2 | 0.2 | 9.8 | 11.2 |
Acquisitions/Disposals of subsidiaries | 2.4 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
Other investments | 0.3 | 0.0 | 0.3 | 0.4 | 0.4 | 0.4 |
Change in borrowings | -5.2 | 3.9 | -4.7 | 0.0 | 0.0 | 0.0 |
Dividends paid | -2.0 | -1.9 | -1.2 | -2.7 | -2.3 | -2.7 |
Repayment of leasing debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Others | -2.6 | -0.7 | 3.3 | -1.4 | -1.4 | -1.4 |
Changes in exchange rates | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Change in net cash over the year | -3.0 | 4.1 | 6.0 | -3.4 | 6.6 | 7.6 |
ROA (%) | 2.6% | 2.3% | 4.0% | 4.9% | 3.8% | 4.1% |
ROE (%) | 6.5% | 5.7% | 9.5% | 11.0% | 8.5% | 8.9% |
ROCE (%) | 5.2% | 4.6% | 7.6% | 6.2% | 7.3% | 8.3% |
Classification: Internal
EQUITY RESEARCH | TP ICAP MIDCAP | 42 rue Washington, 75008 Paris | More on www.midcapp.com2 Document downloaded by Simone Mieli (TP ICAP (EUROPE)SA)
Document published on
4 November 2022 at 8:29am CET
DISCLAIMER
Analyst certifications
This research report (the "Report") has been approved by Midcap, a business division of TP ICAP (Europe) SA ("Midcap"), an Investment Services Provider authorised and regulated by the Autorité de Contrôle Prudentiel et de Résolution ("ACPR"). By issuing this Report, each Midcap analyst and associate whose name appears within this Report hereby certifies that (i) the recommendations and opinions expressed in the Report accurately reflect the research analyst's and associate's personal views about any and all of the subject securities or issuers discussed herein and (ii) no part of the research analyst's or associate's compensation was, is or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst or associate in the Report.
Methodology
This Report may mention evaluation methods defined as follows:
- DCF method: discounting of future cash flows generated by the company's operations. Cash flows are determined by the analyst's financial forecasts and models. The discount rate used corresponds to the weighted average cost of capital, which is defined as the weighted average cost of the company's debt and the theoretical cost of its equity as estimated by the analyst.
- Comparable method: application of market valuation multiples or those observed in recent transactions. These multiples can be used as references and applied to the company's financial aggregates to deduce its valuation. The sample is selected by the analyst based on the characteristics of the company (size, growth, profitability, etc.). The analyst may also apply a premium/discount depending on his perception of the company's characteristics.
- Assets and liabilities method: estimate of the value of equity capital based on revalued assets adjusted for the value of the debt.
- Discounted dividend method: discounting of estimated future dividend flows. The discount rate used is generally the cost of capital.
- Sum of the parts: this method consists of estimating the various activities of a company using the most appropriate valuation method for each of them, then realizing the sum of the parts.
Conflict of Interests
G. Midcap and the Issuer have agreed to the provision by the former to the latter of a service for the production and distribution of the investment recommendation on the said Issuer: Neodecortech
H. TPICAP Midcap prepared this document on behalf of BPER Banca S.p.A acting as specialist in accordance with article 2.3.4 of Rules of the Markets (and related instructions) organized and managed by Borsa Italiana S.p.A.: Neodecortech
History of investment rating and target price - Neodecortech
TARGET PRICE AND RATING HISTORY FOR | |||||||||||||
9 Jan | 29 Jun | 22 Oct | 1 Feb | 19 Apr | 12 May | 6 Jul | 8 Sep | 23 Feb | 16 Mar | ||||
Buy : €4.6 | Buy : €4.4 | Buy : €4.6 | Buy : €4.8 | Buy : €5.5 | Buy : €5.7 | Buy : €5.8 | Buy : €6.4 | Buy : €6.3 | Buy : €5.8 | ||||
5 | 180 | ||||||||||||
5 | 160 | ||||||||||||
4 | 140 | ||||||||||||
4 | |||||||||||||
3 | 120 | ||||||||||||
2 | 100 | ||||||||||||
2 | Jan-20 | Apr-20 | Jul-20 | Oct-20 | Jan-21 | Apr-21 | Jul-21 | Nov-21 | Feb-22 | May-22 | Aug-22 | 80 | |
Oct-19 | Nov-22 | ||||||||||||
12 May | 16 May | ||||||||||||
Buy : €5.2 | Buy : €5.3 | ||||||||||||
Neodecortech (L Axis) | FTSE Italy (R Axis) | Data source: FactSet Prices and Ratings | |||||||||||
Classification: Internal
EQUITY RESEARCH | TP ICAP MIDCAP | 42 rue Washington, 75008 Paris | More on www.midcapp.com3 Document downloaded by Simone Mieli (TP ICAP (EUROPE)SA)
Document published on | ||
4 November 2022 at 8:29am CET | ||
Distribution of Investment Ratings | ||
Rating | Recommendation Universe* | Portion of these provided with investment |
banking services** | ||
Buy | 86% | 65% |
Hold | 13% | 39% |
Sell | 1% | 0% |
Under review | 1% | 100% |
Midcap employs a rating system based on the following:
Buy: Expected to outperform the markets by 10% or more over a 6 to 12 months horizon.
Hold: expected performance between -10% and +10% compared to the market over a 6 to 12 months horizon.
Sell: Stock is expected underperform the markets by 10% or more over a 6 to 12 months horizon.
The history of ratings and target prices for the Issuers covered in this report are available on request at https://researchtpicap.midcapp.com/en/disclaimer.
Classification: Internal
EQUITY RESEARCH | TP ICAP MIDCAP | 42 rue Washington, 75008 Paris | More on www.midcapp.com4 Document downloaded by Simone Mieli (TP ICAP (EUROPE)SA)
Document published on
4 November 2022 at 8:29am CET
General Disclaimer
This Report is confidential and is for the benefit and internal use of the selected recipients only. No part of it may be reproduced, distributed, or transmitted without the prior written consent of Midcap
This Report is published for information purposes only and does not constitute a solicitation or an offer to buy or sell any of the securities mentioned herein. The information contained in this Report has been obtained from sources believed to be reliable, Midcap makes no representation as to its accuracy or completeness. The reference prices used in this Report are closing prices of the day before the publication unless otherwise stated. All opinions expressed in this Report reflect our judgement at the date of the documents and are subject to change without notice. The securities discussed in this Report may not be suitable for all investors and are not intended to recommend specific securities, financial instruments, or strategies to particular clients. Investors should make their own investment decisions based on their financial situation and investment objectives. The value of the income from your investment may vary due to changes in interest rates, changes in the financial and operating conditions of companies and other factors. Investors should be aware that the market price of the securities discussed in this Report may be volatile. Due to the risk and volatility of the industry, the company, and the market in general, at the current price of the securities, our investment rating may not correspond to the stated price target. Additional information regarding the securities mentioned in this Report is available on request.
This Report is not intended for distribution or use by any entity who is a citizen or resident of, or an entity located in any locality, territory, state, country, or other jurisdiction where such distribution, publication, availability, or use would be contrary to or limited by law or regulation. Entity or entities in possession of this Report must inform themselves about and comply with any such restrictions, including MIFID II. This Report is only intended for persons who are Eligible Counterparties or Professional Clients within the meaning of MIFID II regulation. It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. The Report is subject to restricted circulation. The research was conducted in accordance with the provisions of the Charter. Midcap has adopted effective administrative and organizational arrangements, including "information barriers", to prevent and avoid conflicts of interest regarding investment recommendations. The remuneration of financial analysts who participate in the preparation of the recommendation is not linked to the corporate finance activity.
Classification: Internal
EQUITY RESEARCH | TP ICAP MIDCAP | 42 rue Washington, 75008 Paris | More on www.midcapp.com5 Document downloaded by Simone Mieli (TP ICAP (EUROPE)SA)
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Neodecortech S.p.A. published this content on 04 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2022 14:01:08 UTC.